Industry Focus

Motley Fool's Kristine Harjes and Todd Campbell discuss whether investors ought to be buying 3 of biotech's worst performing stocks over the past month.

Direct download: 150902_IF_Healthcare.mp3
Category:Podcast -- posted at: 2:03pm EST